Eurofarma Laboratorios S.A.

2 marketed · 22 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: